TELEFLEX INC (TFX) Stock Price, Forecast & Analysis
USA - New York Stock Exchange - NYSE:TFX - US8793691069 - Common Stock
TFX Key Statistics, Chart & Performance
The current stock price of TFX is 126.53 USD. In the past month the price increased by 5.6%. In the past year, price decreased by -27.54%.
TFX Latest News, Press Relases and Analysis
TFX Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.46 | 220.91B | ||
| ISRG | INTUITIVE SURGICAL INC | 68.79 | 209.96B | ||
| BSX | BOSTON SCIENTIFIC CORP | 33.44 | 146.24B | ||
| SYK | STRYKER CORP | 27.92 | 140.63B | ||
| BDX | BECTON DICKINSON AND CO | 14.06 | 57.86B | ||
| IDXX | IDEXX LABORATORIES INC | 56.67 | 57.06B | ||
| EW | EDWARDS LIFESCIENCES CORP | 33.01 | 49.23B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 18.68 | 39.07B | ||
| RMD | RESMED INC | 25.07 | 36.23B | ||
| DXCM | DEXCOM INC | 37.69 | 27.34B | ||
| PODD | INSULET CORP | 65.46 | 21.05B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.45 | 18.37B |
Related stock screener links
About TFX
Company Profile
Teleflex, Inc. engages in the provision of medical technology products. The company is headquartered in Wayne, Pennsylvania and currently employs 14,100 full-time employees. The firm offers a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology. The company primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. The company operates in three segments: the Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). Its vascular access product portfolio includes Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous (bone access) systems. Its interventional product offerings consist of a portfolio of Arrow branded intra-aortic balloon pumps and catheters, GuideLiner, Turnpike and TrapLiner catheters, Pulsar-18 T3 Self-Expanding 4F Stent and Orsiro Mission Drug Eluting Stent.
Company Info
TELEFLEX INC
550 E Swedesford Rd, Suite 400
Wayne PENNSYLVANIA 19087 US
CEO: Liam J. Kelly
Employees: 14100
Phone: 16102256800
TELEFLEX INC / TFX FAQ
What does TELEFLEX INC do?
Teleflex, Inc. engages in the provision of medical technology products. The company is headquartered in Wayne, Pennsylvania and currently employs 14,100 full-time employees. The firm offers a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology. The company primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. The company operates in three segments: the Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). Its vascular access product portfolio includes Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous (bone access) systems. Its interventional product offerings consist of a portfolio of Arrow branded intra-aortic balloon pumps and catheters, GuideLiner, Turnpike and TrapLiner catheters, Pulsar-18 T3 Self-Expanding 4F Stent and Orsiro Mission Drug Eluting Stent.
What is the current price of TFX stock?
The current stock price of TFX is 126.53 USD. The price increased by 1.37% in the last trading session.
Does TFX stock pay dividends?
TELEFLEX INC (TFX) has a dividend yield of 1.11%. The yearly dividend amount is currently 1.36.
What is the ChartMill technical and fundamental rating of TFX stock?
TFX has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
What is the analyst forecast for TFX stock?
21 analysts have analysed TFX and the average price target is 140.78 USD. This implies a price increase of 11.27% is expected in the next year compared to the current price of 126.53.
What is the expected growth for TFX stock?
The Revenue of TELEFLEX INC (TFX) is expected to grow by 7.68% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
Can you provide the market cap for TELEFLEX INC?
TELEFLEX INC (TFX) has a market capitalization of 5.59B USD. This makes TFX a Mid Cap stock.
TFX Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to TFX. When comparing the yearly performance of all stocks, TFX is a bad performer in the overall market: 80.18% of all stocks are doing better.
TFX Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to TFX. Both the profitability and the financial health of TFX get a neutral evaluation. Nothing too spectacular is happening here.
TFX Financial Highlights
Over the last trailing twelve months TFX reported a non-GAAP Earnings per Share(EPS) of 14.2. The EPS increased by 5.19% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -4.17% | ||
| ROE | -8.58% | ||
| Debt/Equity | 0.67 |
TFX Forecast & Estimates
21 analysts have analysed TFX and the average price target is 140.78 USD. This implies a price increase of 11.27% is expected in the next year compared to the current price of 126.53.
For the next year, analysts expect an EPS growth of 1.67% and a revenue growth 7.68% for TFX